Company news

Impedimed Limited news in 2021

Impedimed Limited's news releases, calls and decks from 2021, newest first.

View company

Share Purchase Plan Successfully Completed

November 17, 2021

AGM Presentation - November 2021

November 9, 2021

2021 Annual General Meeting - Chairmans Address

November 9, 2021

AstraZeneca extends and increases HF & Renal Contract

November 4, 2021

Share Purchase Plan Offer Booklet

November 3, 2021

ImpediMeds Share Purchase Plan Opens

November 3, 2021

Capital Raising Presentation

October 26, 2021

ImpediMed Completes A$35 Million Institutional Placement

October 26, 2021

PREVENT Trial Successful, Statistically Significant Results

October 19, 2021

New Corporate Oncology Account with Icon Group

September 29, 2021

SOZO Heart Failure Program Initiated at AdvocateAuroraHealth

September 26, 2021

HFSA Abstracts Demonstrate Utility of SOZO for HF Patients

September 12, 2021

Receipt of $1.8 Million R&D Tax Incentive Refund

August 24, 2021

FDA Grants Breakthrough Device Designation for Renal Failure

August 22, 2021

Official Release of SOZO Version 4.0 Software

May 24, 2021

ACC Abstract Demonstrates Potential of SOZO in Heart Failure

May 4, 2021

Appendix 4C - Quarter ended 31 March 2021

April 27, 2021

FDA Clearance for SOZO Heart Failure Index

April 21, 2021

SOZO Clinical Utility in Heart Failure Published

April 7, 2021

Option Exercise and Preliminary Q3 FY21 Cashflow Results

April 6, 2021

ImpediMed Achieves Milestone 200,000 SOZO Patient Tests

March 3, 2021

Appendix 4D - Half-Year Results Ended 31 December 2020

February 21, 2021

American College of Cardiology Accepts SOZO HF Abstract

February 11, 2021

Appendix 4C - Quarter ended 31 December 2020

January 27, 2021

PREVENT Trial Finishes, Final Patient Completes Follow-up

January 11, 2021

Option Exercise and Preliminary Quarterly Cash Flow Results

January 6, 2021

Decks in 2021